Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.

source https://www.nytimes.com/2024/10/02/health/lenacapavir-hiv-shot-prep.html